ICPT - Intercept Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
50,517
84,709
58,151
70,055
Other short-term investments
435,049
334,980
411,516
582,567
Total cash
490,909
429,389
477,170
657,347
Net receivables
26,862
47,617
41,549
38,044
Other current assets
22,356
25,286
27,022
25,924
Total current assets
540,127
502,292
477,170
721,315
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,787
29,320
35,530
32,153
Accumulated depreciation
-3,800
-19,824
-16,877
-13,705
Net property, plant and equipment
987
9,496
18,653
18,448
Other long-term assets
11,584
8,619
9,027
8,462
Total non-current assets
13,584
24,731
103,319
33,571
Total assets
553,711
527,023
580,489
754,886
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
109,569
-
-
-
Accounts payable
14,234
18,132
24,594
18,975
Taxes payable
3,144
-
-
-
Accrued liabilities
76,866
112,180
111,138
104,052
Deferred revenues
-
-
-
0
Other current liabilities
1,527
8,952
8,942
6,039
Total current liabilities
230,077
166,817
179,076
162,005
Non-current liabilities
Long-term debt
223,104
539,782
560,582
532,078
Deferred revenues
-
-
-
0
Other long-term liabilities
7,453
-
-
9,247
Total non-current liabilities
230,557
544,168
568,266
541,325
Total liabilities
460,634
710,985
747,342
703,330
Stockholders' equity
Common stock
42
30
33
33
Retained earnings
-2,136,888
-2,489,772
-2,398,346
-2,123,466
Accumulated other comprehensive income
-8,256
-2,873
-2,477
-1,144
Total stockholders' equity
93,077
-183,962
-166,853
51,556
Total liabilities and stockholders' equity
553,711
527,023
580,489
754,886